Vera Therapeutics (VERA) Change in Acquisitions & Divestments (2022 - 2026)

Vera Therapeutics (VERA) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $87.9 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 17.25% year-over-year to $87.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $487.8 million (up 39.57% YoY) and the FY2025 annual result came in at $506.2 million, up 84.09% from the prior year.
• Change in Acquisitions & Divestments slipped to $87.9 million in Q1 2026, from $105.3 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $168.6 million in Q3 2025 to a low of $16.0 million in Q2 2022.
• A 5-year average of $70.2 million and a median of $65.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments jumped 235.36% — and 2026, when it retreated 17.25%.
• Tracing VERA's Change in Acquisitions & Divestments over 5 years: stood at $24.0 million in 2022, then soared by 199.25% to $71.8 million in 2023, then advanced by 2.03% to $73.3 million in 2024, then jumped by 43.65% to $105.3 million in 2025, then decreased by 16.48% to $87.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $87.9 million (Q1 2026), $105.3 million (Q4 2025), and $168.6 million (Q3 2025), per Business Quant data.